Joincare Pharm earnings, Revenue miss in Q3
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Joincare Pharmaceutical Group Industry Co Ltd (600380)
The Joincare Pharm share price today is 9.96, view SS 600380 stock exchange data. Track the latest Joincare Pharm share price with real-time updates on 600380 stock performance including market cap, day range, 52-week range and dividend yield. Access 600380 charts, earnings dates and analyst estimates to support your investment decisions.
Shanghai
Currency in CNY
9.96
+0.09(+0.91%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.90
10.17
52 wk Range
9.44
14.21
600380 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.9010.17
52 wk Range
9.4414.21
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.21%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600380 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
15.74
Upside
+57.98%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Joincare Pharm earnings, Revenue miss in Q3
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.74
(+57.98% Upside)
Earnings
Latest Release
25-04-2026
EPS / Forecast
-- / --
Revenue / Forecast
3.72B / --
Compare 600380 to Peers and Sector
Metrics to compare | 600380 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600380PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.5x | 17.6x | −0.4x | |
PEG Ratio | −23.55 | 0.34 | 0.00 | |
Price/Book | 1.1x | 2.0x | 2.6x | |
Price / LTM Sales | 1.2x | 2.6x | 3.0x | |
Upside (Analyst Target) | 59.4% | 45.2% | 57.3% | |
Fair Value Upside | Unlock | 23.9% | 8.9% | Unlock |
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle’s American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Joincare Pharm (600380) Share Price Today?
The Joincare Pharm share price today is 9.96.
What is the current Joincare Pharm (600380) share price and day range?
As of 24-06-2026, the Joincare Pharm share price is 9.96, with a previous close of 9.87. The share price has ranged from 9.90 to 10.17 today, while the 52-week range spans from 9.44 to 14.21.
What Is the Joincare Pharm Market Cap?
As of today, Joincare Pharm market cap is 17.78B.
Does Joincare Pharm Pay Dividends? What's The Current Dividend Yield?
The Joincare Pharm dividend yield is 2.21%.
What Is the Joincare Pharm (600380) Share Price Target?
The average 12-month share price target for Joincare Pharm is 15.74, with a high estimate of 16 and a low estimate of 15.47. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +57.98% Upside potential.
What Is Joincare Pharm's Earnings Per Share (TTM)?
The Joincare Pharm EPS (TTM) is 0.73.
When Is the Next Joincare Pharm Earnings Date?
Joincare Pharm will release its next earnings report on 20-08-2026.
From a Technical Analysis Perspective, Is 600380 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Joincare Pharm Trade On?
Joincare Pharm is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Joincare Pharm?
The stock symbol for Joincare Pharm is "600380."
How Many Times Has Joincare Pharm Stock Split?
Joincare Pharm has split 6 times.
How Many Employees Does Joincare Pharm Have?
Joincare Pharm has 13575 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.